Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 16, Issue 5, 2009, Pages 655-660

  Cheung, Tan To ^a   Ng, Kelvin K ^a   Poon, Ronnie T ^a   Fan, Sheung Tat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Intolerance; Radiofrequency ablation; Tolerance

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; INDOCYANINE GREEN;

ABDOMINAL BLEEDING; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER DIAGNOSIS; CANCER RECURRENCE; COMORBIDITY; CONTROLLED STUDY; ESOPHAGUS VARICES BLEEDING; FEMALE; GENERAL ANESTHESIA; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERBILIRUBINEMIA; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PANCREATITIS; PATIENT MONITORING; PLEURA EFFUSION; RADIOFREQUENCY ABLATION; RISK FACTOR; SEPTICEMIA; THROMBOCYTE COUNT; TREATMENT DURATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70049104909     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-009-0103-9     Document Type: Article

References (25)

1. Fan ST, et al. Hepatectomy for hepatocellular carcinoma: The surgeon's role in long-term survival. Arch Surg. 1999;134:1124-30.
2. Fan ST, et al. Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths. Ann Surg. 1999;229:322-30.
3. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon's perspective. Ann Surg. 2002;235:466-86.
4. Mulier S, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;89:1206-22.
5. Solbiati L, et al. Hepatic metastases: Percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology. 1997;205:367-73.
6. Curley SA, Izzo F, Ellis LM, Nicolas VJ, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000;232:381-91.
7. Curley SA. Outcomes after surgical treatment of colorectal cancer liver metastases. Semin Oncol. 2005;32:S109-11.
8. Curley SA, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients. Ann Surg. 1999;230:1-8.
9. Chow DH, et al. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: A comparative study. J Surg Oncol. 2006;94:565-71.
10. Raut CP, et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol. 2005;12:616-28.
11. Ng KK, Poon RT. Current treatment strategy for hepatocellular carcinoma. Saudi Med J. 2007;28:1330-8.
12. Livraghi T, et al. Percutaneous radio-frequency ablation of liver metastases from breast cancer: Initial experience in 24 patients. Radiology. 2001;220:145-9.
13. Livraghi T, et al. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection. Radiology. 1999;210:655-61.
14. Lam CM, et al. Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre. Br J Surg. 2004;91:334-8.
15. Bowles BJ, et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg. 2001;136:864-9.
16. Belghiti J, Carr BI, Greig PD, Lencioni R, Poon RT. Treatment before liver transplantation for HCC. Ann Surg Oncol. 2008;15:993-1000.
17. Lencioni RA, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228:235-40.
18. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology. 2004;127:1714-23.
19. Solbiati L, et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: Treatment and follow-up in 16 patients. Radiology. 1997;202:195-203.
20. Curley SA, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004;239:450-8.
21. Wong SL, Edwards MJ, Chao C, Simpson D, McMasters KM. Radiofrequency ablation for unresectable hepatic tumors. Am J Surg. 2001;182:552-7.
22. Goldberg SN, et al. Tissue ablation with radiofrequency: Effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol. 1995;2:399-404.
23. Ng KK, et al. Safety limit of large-volume hepatic radiofrequency ablation in a rat model. Arch Surg. 2006;141:252-8.
24. Bleicher RJ, et al. Radiofrequency ablation in 447 complex unresectable liver tumors: Lessons learned. Ann Surg Oncol. 2003;10:52-8.
25. Lau H, et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg. 1997;84:1255-9.